OptimizeRx Corporation
OPRX
$15.27
-$0.11-0.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.71% | 33.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.71% | 33.14% | |||
| Cost of Revenue | -19.02% | 23.02% | |||
| Gross Profit | -6.00% | 39.65% | |||
| SG&A Expenses | 0.10% | 0.06% | |||
| Depreciation & Amortization | 0.56% | -1.83% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.65% | 8.17% | |||
| Operating Income | -35.72% | 250.85% | |||
| Income Before Tax | -38.76% | 152.16% | |||
| Income Tax Expenses | 49.17% | 116.68% | |||
| Earnings from Continuing Operations | -49.15% | 169.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -49.15% | 169.67% | |||
| EBIT | -35.72% | 250.85% | |||
| EBITDA | -27.58% | 452.09% | |||
| EPS Basic | -49.40% | 169.52% | |||
| Normalized Basic EPS | -38.93% | 152.03% | |||
| EPS Diluted | -50.00% | 166.67% | |||
| Normalized Diluted EPS | -40.14% | 150.68% | |||
| Average Basic Shares Outstanding | 0.35% | 0.22% | |||
| Average Diluted Shares Outstanding | 2.34% | 2.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||